Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage.

Literature DB >> 16763655

Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage.

C S H Tan, H-T Wong, B-A Lim, O K Hee, T H Lim.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16763655 DOI： 10.1038/sj.eye.6702455

Source DB: PubMed Journal: Eye (Lond) ISSN： 0950-222X Impact factor: 3.775

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Genetic influence on visual outcomes of polypoidal choroidal vasculopathy.

Authors: Colin S Tan; Wei Kiong Ngo; Louis W Lim; Tock Han Lim
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2015-09-15 Impact factor: 3.117

2. Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab.

Authors: C S Tan; W K Ngo; L W Lim; T H Lim
Journal: Eye (Lond) Date: 2015-06-19 Impact factor: 3.775

3. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients.

Authors: Suk Ho Byeon; Sung Chul Lee; Hyun-Sub Oh; Sung Soo Kim; Hyoung Jun Koh; Oh Woong Kwon
Journal: Jpn J Ophthalmol Date: 2008-03-28 Impact factor: 2.447

4. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

Authors: Colin S Tan; Wei Kiong Ngo; Jian Ping Chen; Nikolle W Tan; Tock Han Lim
Journal: Br J Ophthalmol Date: 2015-03-10 Impact factor: 4.638

10. EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study.

Authors: Colin S Tan; Wei Kiong Ngo; Louis W Lim; Nikolle W Tan; Tock H Lim
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-05-03 Impact factor: 3.117

Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage.

1. Genetic influence on visual outcomes of polypoidal choroidal vasculopathy.

2. Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab.

3. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients.

4. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

5. Massive submacular hemorrhage resulting in acute angle closure.

6. Acute angle closure glaucoma secondary to polypoidal choroidal vasculopathy - a devastating complication.

7. Macular Hole Secondary to Polypoidal Choroidal Vasculopathy.

8. Submacular hemorrhage from polypoidal choroidal vasculopathy after cataract surgery.

9. Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy.

10. EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study.